MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Blue light therapy glasses in Parkinson’s disease: patients’ experience and effectiveness

    K. Smilowska, D. van Wamelen, A. Schoutens, M. Meinders, B. Bloem (Nijmegen, Netherlands)

    Objective: We aimed to assess how patients experience the use of blue light glasses, a novel way of delivering light therapy, aiming to optimise compliance…
  • 2019 International Congress

    Autonomic features in E46K-SNCA carriers

    M. Carmona-Abellán, I. Gabilondo, A. Murueta, V. Khurana, R. Luquin, B. Tijero, R. Del Pino, M. Acera, R. Sanchez-Pernaute, JC. Gomez-Esteban (Bilbao, Spain)

    Objective: To evaluate structural and functional integrity of small autonomic nerve fibers and phosphorylated alpha-synuclein (p-syn) deposition in the skin of E46K-SNCA carriers as compared…
  • 2019 International Congress

    Are we underestimating the dysautonomic burden in GBA related a-synucleinopathies?

    G. Lazzeri, E. Monfrini, I. Trezzi, M. Vizziello, M. Percetti, G. Franco, L. Borellini, A. Arighi, A. Di Fonzo (Milan, Italy)

    Objective: The aim of the present study is to understand the prevalence of dysautonomic symptoms in a cohort of Italian glucocerebrosidase (GBA) mutated patients with…
  • 2019 International Congress

    Clinical Management of Incipient Wearing-off with the 19-Items Wearing off Questionnaire (WOQ-19)

    V. Puente Périz, I. Navalpotro Gómez, A. Crespo Cuevas, A. Puig Pijuan, A. Fernandez Lebrero, D. Lahoz (Barcelona, Spain)

    Objective: To evaluate the use of the 19-items Wearing off Questionnaire (WOQ-19) to detect fluctuations in patients with non-advanced Parkinson's disease (PD) and to evaluate…
  • 2019 International Congress

    Can we hear pathology in premanifest Huntington’s disease? Acoustic and listener-based analysis of speech

    J. Chan, C. Shirbin, J. Stout, A. Vogel (Melbourne, Australia)

    Objective: The present study evaluated the ability of acoustic and listener-based perceptual measures to differentiate speech deficits in the premanifest and early stages of HD…
  • 2019 International Congress

    The Roche HD Natural History Study – an external comparator by design

    G. Hooper, G. Palermo, F. Hlavac, C. Finnegan, E. Frick, L. Boak, R. Doody, S. Schobel (Welwyn Garden City, United Kingdom)

    Objective: The Roche Natural History (NH) study in Huntington’s disease (HD) (NCT03664804) is a prospective, longitudinal cohort study designed to provide further clinical validation of…
  • 2019 International Congress

    Burden of Huntington’s disease in the US: Analysis of an insured population

    K. Raimundo, J. Luo, R. Tan, T. To, R. Fuller, J. Warner (South San Francisco, CA, USA)

    Objective: To describe the healthcare resource utilization (HRU) in Huntington’s disease (HD) in private (commercial) and public (Medicare and Medicaid) insurance plans in the US.…
  • 2019 International Congress

    Sustained mutant huntingtin lowering in the brain and cerebrospinal fluid of Huntington disease minipigs mediated by AAV5-miHTT gene therapy

    A. Vallès-Sanchez, A. Stam, C. Brouwers, J. Klíma, B. Bohuslavová, R. Pintauro, M. Sogorb-Gonzalez, L. Paerels, V. Fodale, A. Bresciani, Z. Ellederová, B. Blits, J. Motlik, S. van Deventer, M. Evers, P. Konstantinova (Amsterdam, Netherlands)

    Objective: To assess the translatability and long-term efficacy of gene therapy-mediated huntingtin (HTT)-lowering in a large animal model of Huntington disease (HD), transgenic HD (tgHD)…
  • 2019 International Congress

    A randomized clinical trial of multimodal balance training with rhythmical cues: effects on freezing of gait in Parkinson’s disease

    T. Capato, N. de Vries, J. Inthout, J. Ramjith, E. Barbosa, J. Nonnekes, B. Bloem (Nijmegen, Netherlands)

    Objective: To investigate whether the multimodal training is more effective in improving balance and gait in freezers versus non-freezers. Background: Non-pharmacological interventions are increasingly used…
  • 2019 International Congress

    Lack of Notable Skin Reactions from a Novel Levodopa/Carbidopa Prodrug after 10 Days of Repeated 24-Hour Continuous Subcutaneous Infusion at the Same Administration Site

    M. Facheris, X. Qi, C. Locke, M. Rosebraugh, J. Benesh (North Chicago, IL, USA)

    Objective: To assess the skin safety and tolerability of 24-hour continuous subcutaneous infusion (CSCI) of ABBV-951. Background: Therapeutic approaches for advanced Parkinson’s disease (aPD) patients…
  • « Previous Page
  • 1
  • …
  • 179
  • 180
  • 181
  • 182
  • 183
  • …
  • 217
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley